Why Bioavailability Matters: Nutrition Intake vs. Nutrition Absorption
2024-10-30 | EffePharm
Summary
In the crowded market of dietary supplements, bioavailability has become a key factor influencing consumer choices and product effectiveness. It refers to how well and how much of the active ingredients in supplements are absorbed and utilized by the body. Understanding bioavailability is essential, as it directly impacts the effectiveness of nutrients, helping consumers make informed health decisions.
Consumers are increasingly discerning about their choices in today’s crowded nutrient supplement market. They are looking beyond flashy packaging and catchy marketing slogans to focus on quality and real effectiveness.
One critical factor gaining attention is bioavailability, a term that originated in biopharmaceuticals but is now essential in evaluating dietary supplements. Bioavailability refers to the efficiency and thoroughness with which the body absorbs and utilizes the active ingredients in these products. This measure directly influences both the effectiveness and nutritional value of a supplement. As a result, bioavailability has become a silent yet powerful judge in the competitive landscape of dietary supplements, shaping consumer preferences and market dynamics.
1. What is Bioavailability
Bioavailability refers to the extent to which active ingredients in nutritional products are absorbed and utilized by the body. In simple terms, it measures how effectively our body can take in nutrients after we consume them. Nutritional scientists understand that our bodies aren’t perfect at absorbing everything we eat. Not all nutrients make it into the bloodstream; some can be broken down in the stomach or intestines before they can be used, while others may be expelled from the body without being absorbed.
To evaluate bioavailability, scientists look at three main factors: the peak concentration (Cmax), which is the highest level of the active substance in the blood after taking a supplement; the time to peak (tmax), which indicates how long it takes for this peak level to be reached; and the area under the curve (AUC0-t), which measures the overall exposure of the bloodstream to the active substance over time. Understanding bioavailability enables us to assess the effectiveness of nutritional supplements, allowing us to make informed choices for our health.
Below is an experimental design for assessing the bioavailability of different supplement formulations in human or animal models. By administering supplements and collecting blood samples at various intervals, followed by precise measurement of active ingredient concentrations using advanced techniques such as High-Performance Liquid Chromatography (HPLC) and Ultra-High-Performance Liquid Chromatography-Mass Spectrometry (UHPLC-MS), researchers can analyze key bioavailability metrics. This approach enables a detailed comparison of how different formulations impact nutrient absorption and overall bioavailability, informing more informed choices for optimal liposomal design.
Common Experimental Design for Nutrient Bioavailability
Experimental Design for Bioavailability of Nutritional Supplements
Preparation: Human volunteers or animals will be randomly assigned to groups and given a single dose of different nutritional supplement formulations, each containing the same amount of active ingredients.
Sample Collection: Blood samples will be taken at various time points: before administration (0 hours) and after administration (e.g., 0.5, 1, 2, 4, 8, and 12 hours).
Sample Processing and Analysis: The blood samples will be processed using methods such as High-Performance Liquid Chromatography (HPLC) or Ultra-High-Performance Liquid Chromatography-Mass Spectrometry (UHPLC-MS) to measure the concentration of active ingredients.
Data Processing: A concentration-time curve will be created with time on the x-axis and active ingredient concentration on the y-axis. The area under the curve (AUC0-t) will be calculated to quantify overall exposure.
Result Analysis: The peak concentration (Cmax) will be assessed to determine if an effective level of the active ingredient is achieved. Time to peak (tmax) will evaluate the absorption rate. Bioavailability will be analyzed by comparing AUC0-t values between the formulation and regular drug groups to determine the enhancement factor.
Liposomal Glutathione Bioavailability Experiment
In this experiment, different groups of rats were orally administered either regular glutathione or LipoAvail™ glutathione (both at the same dose) via gavage. Blood samples were collected at various time points: before administration (0 hours) and then at 0.5 hours, 1 hour, 2 hours, 4 hours, 8 hours, and 12 hours after administration. After processing the samples through centrifugation, we measured the glutathione levels using High Performance Liquid Chromatography (HPLC). We then plotted a concentration-time curve and calculated the area under the curve (AUC0-12h) to determine bioavailability.
Results: The AUC0-12h for the LipoAvail™ glutathione group was significantly higher than that of the regular glutathione group, indicating that LipoAvail™ enhances glutathione bioavailability by approximately 13 times.
2. Why is Bioavailability Important?
Supplements designed for high bioavailability are more effective because they help the body absorb more nutrients with fewer doses. In simple terms, bioavailability is crucial for the effectiveness of active ingredients. Many common active ingredients in nutritional supplements play important roles, such as reducing inflammation, acting as potent antioxidants, and supporting cardiovascular and neurological health.
While macronutrients like carbohydrates and fats are highly bioavailable, beneficial micronutrients—such as vitamins, minerals, flavonoids, and carotenoids—can be more challenging for the body to absorb. These micronutrients often encounter issues such as poor solubility (especially in water) and stability problems. Such challenges can reduce their bioavailability, limiting their ability to deliver full health benefits to the body.
Two notable examples in the market illustrate the challenges of bioavailability. Glutathione is recognized for its powerful antioxidant properties and skin rejuvenation benefits, but it often faces stability issues that can diminish its effectiveness. Meanwhile, silymarin, a popular liver-protective ingredient, has poor water solubility, which limits its absorption.
Glutathione
Glutathione is a crucial antioxidant composed of three amino acids. It plays an essential role in regulating metabolism within cells and possesses strong antioxidant properties, which help detoxify the liver and support the immune system, among other functions. Due to its benefits, glutathione is widely used in medicine and is a popular dietary supplement.
However, glutathione faces some challenges that can limit its effectiveness. Its molecular structure contains a reactive sulfhydryl group (-SH), making it susceptible to oxidation from environmental factors such as light, humidity, and heat. Additionally, during digestion, gastric acid and digestive enzymes can break down glutathione quickly, leading to a loss of its beneficial properties.
Silymarin
Silymarin is a natural flavonoid compound extracted from milk thistle seeds, with silybin as its main active ingredient. Often likened to a “guardian for the liver,” it is widely used in medicine, dietary supplements, and cosmetics for its various benefits, including antioxidant effects, anti-inflammatory properties, liver protection, and immune system support.
However, a significant challenge with silymarin is its low solubility in water, which is only 0.06 mg/mL. Its limited solubility makes it difficult for the body to absorb effectively after oral consumption, resulting in low concentrations of silymarin in the bloodstream. Research shows that free silymarin is quickly eliminated from the body. Consequently, when people take silymarin capsules, much of it is excreted without delivering meaningful health benefits.
These issues mean that many active ingredients in nutritional supplements may not be absorbed effectively by the body, making it difficult to achieve the desired health benefits. Taking large amounts of these supplements can not only fail to deliver the intended effects but also put extra strain on the digestive system.
3. Effe-PLUS Platform
The Effe-PLUS platform is an engineering technology primarily designed to solve problems associated with health supplement ingredients, such as undesirable flavors, poor stability, low bioavailability, and the inability to disperse in cold water, offering differentiated nutritional health solutions to create competitive advantages for customers.
Liposomal technology involves encapsulating active ingredients within minuscule lipid molecules known as liposomes. These liposomes are tiny spheres characterized by bilayer membranes; the outer layer is hydrophilic, while the inner layer is hydrophobic. The phospholipid molecules used in this process closely resemble those that form the membranes of human cells. This distinctive structure enhances the absorption of encapsulated nutrients.
Key Highlights of LipoAvail™️ Liposomal Technology
Lab-Validated Bioavailability: Our technology demonstrates a significant increase in bioavailability, as confirmed by laboratory studies.
High Encapsulation Rate: We achieve a maximized delivery of active ingredients through an efficient encapsulation process.
Authenticity Verification: The authenticity of our liposomes is validated using Transmission Electron Microscopy (TEM).
Controlled Nanoscale Particle Size: All liposomes are maintained at a nanoscale particle size, with a diameter below 100 nm, ensured through advanced homogenization techniques.
Versatile Applications: Our liposomal products exhibit excellent stability and dispersibility, facilitating easy application and absorption across a wide range of uses.
This innovative approach not only improves nutrient delivery but also broadens the potential applications of liposomal formulations.
Microencapsulation is an innovative process that encapsulates active ingredients within microscopic capsules, typically ranging in size from 1 to 5,000 micrometers. This technique yields a solid particulate product, characterized by a thin, uniform coating that protects the active compound.
Key highlights of EncapCirc™️ microencapsulation technology
Superior Mechanical Properties: Uniform particle size with no dust.
Excellent Stability: Content remains stable for up to 2 years.
Outstanding Cold Water Dispersibility: Disperses in cold water within 30 seconds.
Enhanced Bioavailability: Improves the absorption and effectiveness of active ingredients.
Versatile Applications: Suitable for solid beverages, gummies, and premixes.
Micellar technology is an advanced delivery system that forms nano-sized micelles through a spontaneous emulsification process. These micelles comprise active ingredients and various types of emulsifiers, forming an oil-in-water emulsion. The lipophilic components form a lipid core, surrounded by emulsifiers in a water-based phase, allowing active compounds to be incorporated into the core, emulsifier layer, or both.
Key highlights of CelleSperse™ micelles technology
Founded in 2017, EffePharm is a biotech company that offers science-backed bioactive ingredients to address unmet nutritional needs, empowering individuals to take more control of their health and thrive at every stage of life.
EffePharm advocates for innovative bioscience applications, increased accessibility of nutrition, and improved quality of life. Committed to delivering efficacy-verified products to the market, EffePharm has established a portfolio of over 3,000 business partners worldwide, benefiting millions of consumers as they thrive throughout their health and nutrition journeys.
Disclaimer:
Reference available upon request.
The Food and Drug Administration has not evaluated the statements provided herein. This product is not intended to diagnose, treat, cure, or prevent any disease. Claims related to this product may vary by region, as product labeling and associated claims are subject to differing governmental regulations. EffePharm reserves the right to interpret and clarify these statements as necessary.
LipoAvail™, EncapCirc™, and CelleSperse™ are trademarks of EffePharm Ltd.
For media inquiries or further information, please contact EffePharm Marketing: marketing@effepharm.com
These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.
Information on this site is provided for informational purposes only. It is not meant to substitute for medical advice from your physician or other medical professional. You should not use the information contained herein to diagnose or treat a health problem or disease or prescribe any medication. Carefully read all product documentation. If you have or suspect that you have a medical problem, promptly contact your regular healthcare provider.